Becca Agnor, M.S., joined Statistics Collaborative, Inc. (SCI) in 2016. She is a member of the American Statistical Association.
At SCI, Ms. Agnor has worked with clinical trials in a range of disease areas, including cardiovascular disease, Alzheimer’s disease, and oncology. As a biostatistician, she performs statistical analyses, programs datasets, generates graphs, tables, and listings, validates program code, and assists in the writing of study reports, statistical analysis plans, and meeting minutes. Ms. Agnor has served as the project manager and lead statistical programmer for trials evaluating treatments for muscle invasive bladder cancer, myocardial infarction, and myelodysplastic syndrome.
Prior to joining SCI, Ms. Agnor was a graduate research associate at Rho, Inc., working with clinical trials on autoimmune diseases, including type 1 diabetes, rheumatoid arthritis, and lupus. She also interned at the National Cancer Institute where she was involved in research on randomization methods for clinical trials.
She received her B.A. summa cum laude in Mathematics (concentration in statistics) with a minor in Business from Wittenberg University (2014) and her M.S. in Biostatistics from The University of North Carolina-Chapel Hill (2016). Her master’s project was titled “Evaluating imputation methods for values below the limit of detection in type 1 diabetes studies”.
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.